Kaj Blennow

Research.com Recognitions

• 2026 - Research.com Medicine in Sweden Leader Award
• 2026 - Research.com Neuroscience in Sweden Leader Award
• 2025 - Research.com Best Scientists Award
• 2025 - Research.com Medicine in Sweden Leader Award
• 2025 - Research.com Neuroscience in Sweden Leader Award
• 2023 - Research.com Medicine in Sweden Leader Award
• 2022 - Research.com Medicine in Sweden Leader Award
• 2022 - Research.com Neuroscience in Sweden Leader Award
• 2017 - Nordic Medical Prize, SalusAnsvar/Ulf Nilsonnes Foundation for Medical Research

Overview

Best Publications

• NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

  Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  9859
  Citations

• Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

  B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic

  5983
  Citations

• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

  Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  3702
  Citations

• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

  Leslie M. Shaw;Hugo Vanderstichele;Malgorzata Knapik-Czajka;Christopher M. Clark

  2374
  Citations

• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

  Kaj Blennow;Harald Hampel;Michael Weiner;Henrik Zetterberg

  2221
  Citations

• Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

  Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  2178
  Citations

• CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

  Bob Olsson;Ronald Lautner;Ulf Andreasson;Annika Öhrfelt

  2170
  Citations

• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

  Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos

  2113
  Citations

• Gut microbiome alterations in Alzheimer's disease.

  Nicholas M. Vogt;Robert L. Kerby;Kimberly A. Dill-McFarland;Sandra J. Harding

  2017
  Citations

• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

  Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  1996
  Citations

• A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

  Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  1888
  Citations

• Neurofilaments as biomarkers in neurological disorders

  Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl

  1874
  Citations

• Clearance systems in the brain—implications for Alzheimer disease

  Jenna M. Tarasoff-Conway;Roxana O. Carare;Ricardo S. Osorio;Lidia Glodzik

  1670
  Citations

• CSF markers for incipient Alzheimer's disease

  Kaj Blennow;Harald Hampel

  1646
  Citations

• The Amyloid-β Pathway in Alzheimer's Disease.

  Harald Hampel;John Hardy;Kaj Blennow;Kaj Blennow;Christopher Chen

  1638
  Citations

• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  1417
  Citations

• Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.

  Sebastian Palmqvist;Shorena Janelidze;Yakeel T. Quiroz;Yakeel T. Quiroz;Henrik Zetterberg

  1399
  Citations

• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

  Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  1333
  Citations

• Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

  Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  1260
  Citations

• Neurofilament light chain as a biomarker in neurological disorders

  Lorenzo Gaetani;Kaj Blennow;Paolo Calabresi;Massimiliano Di Filippo

  1213
  Citations

• Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

  Giulio Disanto;Christian Barro;Pascal Benkert;Yvonne Naegelin

  1154
  Citations

• Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

  K. Blennow;A. Wallin;H. Ågren;C. Spenger

  1110
  Citations

• An 18-year follow-up of overweight and risk of Alzheimer disease.

  Deborah Gustafson;Elisabet Rothenberg;Kaj Blennow;Bertil Steen

  1068
  Citations

• C-11-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

  Juha O Rinne;David J Brooks;Martin N Rossor;Nick C Fox

  1003
  Citations